Cargando…
Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency
Pancreatic exocrine insufficiency (PEI) is often observed in patients with pancreatic diseases, including chronic pancreatitis, cystic fibrosis, and tumors, or after surgical resection. PEI often results in malnutrition, weight loss and steatorrhea, which together increase the risk of morbidity and...
Autores principales: | Nakajima, Kei, Oshida, Haruki, Muneyuki, Toshitaka, Kakei, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426252/ https://www.ncbi.nlm.nih.gov/pubmed/22936895 http://dx.doi.org/10.2147/CE.S26705 |
Ejemplares similares
-
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
por: Krishnamurty, Devi Mukkai, et al.
Publicado: (2009) -
Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
por: Baker, Susan S
Publicado: (2008) -
A Retrospective Real-World Evidence Evaluation of the Characteristics of Exocrine Pancreatic Insufficiency in Patients With Chronic Pancreatitis and Type 2 Diabetes Treated With Pancrelipase in the United States
por: Rosenberg, Jonathan, et al.
Publicado: (2022) -
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis
por: Konstan, Michael W., et al.
Publicado: (2010) -
Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study
por: Nakajima, Kei, et al.
Publicado: (2013)